Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPK-843 in Pulmonary Mycosis
NCT01125644Phase 3Unknown
- Sponsor
- Proaparts
- Start
- May 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amcipatricin in cryptococcosis, aspergillosis, sponsored by Proaparts. Status: unknown.
02
Drugs
amcipatricin
03
Conditions
cryptococcosisaspergillosis
Beyond the preview
Go deeper on NCT01125644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01125644.